These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19692472)

  • 1. Attenuated strains of influenza A viruses do not induce degradation of RNA polymerase II.
    Rodriguez A; Pérez-González A; Hossain MJ; Chen LM; Rolling T; Pérez-Breña P; Donis R; Kochs G; Nieto A
    J Virol; 2009 Nov; 83(21):11166-74. PubMed ID: 19692472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific residues of PB2 and PA influenza virus polymerase subunits confer the ability for RNA polymerase II degradation and virus pathogenicity in mice.
    Llompart CM; Nieto A; Rodriguez-Frandsen A
    J Virol; 2014 Mar; 88(6):3455-63. PubMed ID: 24403580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II.
    Rodriguez A; Pérez-González A; Nieto A
    J Virol; 2007 May; 81(10):5315-24. PubMed ID: 17344288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered receptor specificity and fusion activity of the haemagglutinin contribute to high virulence of a mouse-adapted influenza A virus.
    Koerner I; Matrosovich MN; Haller O; Staeheli P; Kochs G
    J Gen Virol; 2012 May; 93(Pt 5):970-979. PubMed ID: 22258863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type B and type A influenza polymerases have evolved distinct binding interfaces to recruit the RNA polymerase II CTD.
    Krischuns T; Isel C; Drncova P; Lukarska M; Pflug A; Paisant S; Navratil V; Cusack S; Naffakh N
    PLoS Pathog; 2022 May; 18(5):e1010328. PubMed ID: 35605026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza Virus and Chromatin: Role of the CHD1 Chromatin Remodeler in the Virus Life Cycle.
    Marcos-Villar L; Pazo A; Nieto A
    J Virol; 2016 Jan; 90(7):3694-707. PubMed ID: 26792750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity.
    Amorim MJ; Read EK; Dalton RM; Medcalf L; Digard P
    Traffic; 2007 Jan; 8(1):1-11. PubMed ID: 17132145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses.
    Hussain S; Turnbull ML; Wise HM; Jagger BW; Beard PM; Kovacikova K; Taubenberger JK; Vervelde L; Engelhardt OG; Digard P
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mutations in avian PA in combination with an adaptive mutation in PR8 NP exacerbate the virulence of PR8-derived recombinant influenza A viruses in mice.
    Lee CY; An SH; Kim I; Choi JG; Lee YJ; Kim JH; Kwon HJ
    Vet Microbiol; 2018 Jul; 221():114-121. PubMed ID: 29981696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the genetic stability of the temperature-sensitive PB2 gene mutation of the influenza A/Ann Arbor/6/60 cold-adapted vaccine virus.
    Treanor J; Perkins M; Battaglia R; Murphy BR
    J Virol; 1994 Dec; 68(12):7684-8. PubMed ID: 7966557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-Free and Ribonucleoprotein-Associated Influenza Virus Polymerases Directly Bind the Serine-5-Phosphorylated Carboxyl-Terminal Domain of Host RNA Polymerase II.
    Martínez-Alonso M; Hengrung N; Fodor E
    J Virol; 2016 Jul; 90(13):6014-6021. PubMed ID: 27099314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
    PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene.
    Grimm D; Staeheli P; Hufbauer M; Koerner I; Martínez-Sobrido L; Solórzano A; García-Sastre A; Haller O; Kochs G
    Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6806-11. PubMed ID: 17426143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of wild-type human influenza A virus by acquisition of the PA polymerase and matrix protein genes of influenza A/Ann Arbor/6/60 cold-adapted donor virus.
    Snyder MH; Clements ML; De Borde D; Maassab HF; Murphy BR
    J Clin Microbiol; 1985 Nov; 22(5):719-25. PubMed ID: 4056002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys.
    Snyder MH; Buckler-White AJ; London WT; Tierney EL; Murphy BR
    J Virol; 1987 Sep; 61(9):2857-63. PubMed ID: 2441080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus polymerase subunits co-evolve to ensure proper levels of dimerization of the heterotrimer.
    Chen KY; Santos Afonso ED; Enouf V; Isel C; Naffakh N
    PLoS Pathog; 2019 Oct; 15(10):e1008034. PubMed ID: 31581279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells.
    Vreede FT; Chan AY; Sharps J; Fodor E
    Virology; 2010 Jan; 396(1):125-34. PubMed ID: 19875144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.
    Snyder MH; Betts RF; DeBorde D; Tierney EL; Clements ML; Herrington D; Sears SD; Dolin R; Maassab HF; Murphy BR
    J Virol; 1988 Feb; 62(2):488-95. PubMed ID: 3336068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain.
    Naito T; Mori K; Ushirogawa H; Takizawa N; Nobusawa E; Odagiri T; Tashiro M; Ohniwa RL; Nagata K; Saito M
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.